As discussed in this prior blog post, beginning in 2018 the U.S. Department of Health and Human Services (HHS) reduced reimbursement rates for Medicare prescription drugs to 340B hospitals by nearly thirty percent. The American Hospital Association (AHA) filed suit, and on June 15, 2022 the U.S. Supreme Court ruled that the cuts imposed
340B Reimbursement
HFMA Article Addresses Key Takeaways for Hospitals Following Release of HHS 2023 Hospital Outpatient Payment Proposed Rule
By John W. Kaveney on
Posted in Healthcare
On the heels of last month’s decision by the U.S. Supreme Court reversing cuts by the federal government to hospitals reimbursed under the federal 340B program, this past Friday the Department of Health and Human Services (HHS) released its anticipated 2023 Hospital Outpatient Payment proposed rule. As discussed by Nick Hut of the Healthcare Financial…